Sanjay Subramanian

Currently holds a position at Ocugen Inc

0.5

0.5

Position	Company	Period
Chief Financial Officer	Ocugen Inc	Oct. 1, 2019 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-04-20	2022-04-19	Inozyme Pharma Inc (INZY)	B Purchase	74,890 +9.3% 392.82 US$756,611	74,890 +9.3%	392.82	US$756,611
2021-10-27	2021-10-26	Ocugen Inc (OCGN)	PlS Planned sale	77,431 -16.7% 116.49 US$287,830	77,431 -16.7%	116.49	US$287,830
2021-10-15	2021-10-15	Ocugen Inc (OCGN)	PlS Planned sale	72,213 +1.2% 314.24 US$3,107,373	72,213 +1.2%	314.24	US$3,107,373
2021-06-17	2021-06-15	Ocugen Inc (OCGN)	PlS Planned sale	31,000 -40.5% 7.00 US$217,000	31,000 -40.5%	7.00	US$217,000
2021-05-03	2021-04-29	Ocugen Inc (OCGN)	PlS Planned sale	7,990 -14.9% 10.98 US$87,730	7,990 -14.9%	10.98	US$87,730
2019-10-04	2019-10-02	Ocugen Inc (OCGN)	B Purchase	5,000 +inf% 1.88 US$9,400	5,000 +inf%	1.88	US$9,400